NIH-funded research R01 grant

Noninvasive treatment for enlarged prostate tissue

Official title: Noninvasive histotripsy ablation of fibrotic tissue in benign prostatic hyperplasia

Funded at University of Washington · NIH-10652668 · Data updated 2026-11-12

This study is testing a new, gentle ultrasound treatment called histotripsy to help break down tough tissue in the prostate that causes urinary problems for older men with benign prostatic hyperplasia (BPH), aiming to make treatment easier and quicker without the need for surgery.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 1, 2019
Project endJune 30, 2025
Funding year2023
Award (this year)$601,721
NIH project number5R01DK119310-05
Project IDNIH-10652668 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are men experiencing moderate to severe urinary symptoms related to benign prostatic hyperplasia.

Less likely to help

Patients with severe prostate enlargement requiring immediate surgical intervention may not benefit from this noninvasive approach.

What this research studies

This research investigates a new noninvasive technique called histotripsy, which uses focused ultrasound to break down fibrotic tissue in the prostate caused by benign prostatic hyperplasia (BPH). BPH is a common condition in older men that leads to uncomfortable urinary symptoms. The goal is to provide an effective treatment option that minimizes the need for invasive surgeries, thereby reducing recovery time and complications. Patients will be monitored for improvements in urinary flow and overall quality of life as part of the treatment process.

Why it matters

Potential benefit: If successful, this research could offer a safer and less invasive treatment option for men suffering from urinary symptoms due to BPH.

How similar studies have gone: Previous research has shown promise in using histotripsy for various medical conditions, indicating potential for success in treating BPH.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Schade, George R — University of Washington
  • Study coordinator: Schade, George R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.